Insider · CIK 0001983476
Carl Dambkowski
officerdirector
Files at ORKA (Oruka Therapeutics, Inc.), APGE (Apogee Therapeutics, Inc.). First filing Nov 8, 2024, latest Sep 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 12
$0 bought, $2.3M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | Apogee Therapeutics, Inc. | $103k 2,725 shares | -1% | - | |
| 5Weak | Apogee Therapeutics, Inc. | $103k 2,725 shares | -1% | - | |
| 0Weak | Apogee Therapeutics, Inc. | $455k 10,090 shares | -4% | - | |
| 5Weak | Apogee Therapeutics, Inc. | $101k 2,725 shares | -1% | - | |
| 5Weak | Apogee Therapeutics, Inc. | $97k 2,725 shares | -1% | - | |
| 6Weak | Apogee Therapeutics, Inc. | $140k 3,860 shares | -2% | - | |
| 10Weak | Apogee Therapeutics, Inc. | $48k 1,590 shares | -1% | - | |
| 0Weak | Apogee Therapeutics, Inc. | $143k 3,520 shares | -1% | - | |
| 0Weak | Apogee Therapeutics, Inc. | $192k 4,085 shares | -2% | - | |
| 0Weak | Apogee Therapeutics, Inc. | $221k 4,540 shares | -2% | - | |
| 17Weak | Apogee Therapeutics, Inc. | $307k 6,665 shares | -2% | - | |
| 19Weak | Apogee Therapeutics, Inc. | $394k 6,665 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Common Stock | -1,375 | $135.06 | $186k | 167,123 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Common Stock | -167,123 | - | - | 0 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -110,665 | - | - | 0 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -124,962 | - | - | 0 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -83,690 | - | - | 0 | 39 d ago |
| Sep 3, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,535 | $37.82 | $96k | 233,738 | Sep 5, 2025 |
| Sep 3, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -190 | $38.55 | $7,325 | 233,548 | Sep 5, 2025 |
| Aug 6, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,725 | $37.78 | $103k | 236,273 | Aug 8, 2025 |
| Jul 2, 2025 | APGE Apogee Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,365 | $22.86 | $168k | 249,088 | Jul 3, 2025 |
| Jul 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,409 | $44.77 | $287k | 242,679 | Jul 3, 2025 |
| Jul 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,935 | $45.49 | $134k | 239,744 | Jul 3, 2025 |
| Jul 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -746 | $46.26 | $35k | 238,998 | Jul 3, 2025 |
| Jul 2, 2025 | APGE Apogee Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,365 | $0.00 | $0 | 164,010 | Jul 3, 2025 |
| Jun 4, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,725 | $36.96 | $101k | 241,723 | Jun 6, 2025 |
| Jun 2, 2025 | ORKA Oruka Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,500 | $0.00 | $0 | 17,500 | Jun 3, 2025 |
| May 7, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,725 | $35.75 | $97k | 244,448 | May 9, 2025 |
| Apr 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,471 | $35.56 | $88k | 248,562 | Apr 4, 2025 |
| Apr 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -500 | $37.03 | $19k | 248,062 | Apr 4, 2025 |
| Apr 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -889 | $37.59 | $33k | 247,173 | Apr 4, 2025 |
| Mar 5, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,590 | $30.48 | $48k | 251,033 | Mar 7, 2025 |
| Feb 5, 2025 | APGE Apogee Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +795 | $22.86 | $18k | 256,143 | Feb 7, 2025 |
| Feb 5, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,520 | $40.69 | $143k | 252,623 | Feb 7, 2025 |
| Feb 5, 2025 | APGE Apogee Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -795 | $0.00 | $0 | 171,375 | Feb 7, 2025 |
| Jan 2, 2025 | APGE Apogee Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,360 | $22.86 | $31k | 259,433 | Jan 3, 2025 |
| Jan 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,499 | $46.42 | $70k | 257,934 | Jan 3, 2025 |
| Jan 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,486 | $47.21 | $117k | 255,448 | Jan 3, 2025 |
| Jan 2, 2025 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $47.92 | $4,792 | 255,348 | Jan 3, 2025 |
| Jan 2, 2025 | APGE Apogee Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,360 | $0.00 | $0 | 172,170 | Jan 3, 2025 |
| Dec 11, 2024 | APGE Apogee Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,815 | $22.86 | $41k | 262,613 | Dec 13, 2024 |
| Dec 11, 2024 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,085 | $48.62 | $199k | 258,528 | Dec 13, 2024 |
| Dec 11, 2024 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -455 | $50.00 | $23k | 258,073 | Dec 13, 2024 |
| Dec 11, 2024 | APGE Apogee Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,815 | $0.00 | $0 | 173,530 | Dec 13, 2024 |
| Dec 9, 2024 | APGE Apogee Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +124,962 | $0.00 | $0 | 124,962 | Dec 11, 2024 |
| Dec 4, 2024 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,665 | $46.07 | $307k | 260,798 | Dec 6, 2024 |
| Nov 6, 2024 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,326 | $58.91 | $314k | 268,802 | Nov 8, 2024 |
| Nov 6, 2024 | APGE Apogee Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,339 | $59.96 | $80k | 267,463 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.